Project Grant F32AI188770
Award Date
5/12/25
Completion Date
11/30/27
Dollars Obligated
$148K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Milwaukee, WI 53226, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $189,150 Project Grant to the University of Colorado-Denver under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct exploratory research on new regulators of outer membrane vesicle (OMV) entry into macrophages. The goal is to bridge a major knowledge gap in understanding the upstream mechanisms of how OMVs released by gram-negative bacteria enter macrophages and trigger an inflammatory...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $479,730 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Wisconsin - Madison. The grant supports a 5-year research project to elucidate the mechanisms by which prophages (viral DNA integrated into bacterial genomes) modulate the production of the antimicrobial compound reuterin in the probiotic gut symbiont Limosilactobacilus reuteri. The research aims to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $282,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Institute for Systems Biology. The grant, awarded on September 1, 2024, supports research to investigate the non-canonical role of host caspase-1 in regulating antimicrobial resistance (AMR) of intracellular bacteria, specifically Salmonella. The research aims to elucidate the mechanism by which caspase-1 inhibits...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Rowan University a $474,363 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop novel antimicrobial peptides inspired by the clinically approved compound daptomycin. The research aims to improve the understanding of sequence-structure-activity relationships and leverage non-canonical amino acids to create novel peptides that mimic daptomycin's key mechanisms of calcium...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $219,122 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Illinois to conduct research on novel sRNA-mediated regulation of Rho action in the 3' untranslated region (UTR) of HilD mRNA to affect mRNA stability in Salmonella Typhimurium. The project aims to understand the regulation of the identified sRNAs and their effects on the SPI1 regulatory system, which...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $238,787 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Stony Brook University. The project aims to track the secretion of proteins through the cell envelope of mycobacteria, including pathogens like Mycobacterium tuberculosis, to elucidate the mechanism of the ESX-1 secretion system. The research will utilize innovative approaches such as cell wall-specific protein tagging,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $721,555 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Colorado-Denver. The grant, titled "DNA Transduction in Intestinal Microbiomes and the Spread of Pathogenicity Traits," will fund research to establish high-throughput methods for measuring and identifying transduction - the transfer of genetic material by bacterial viruses (phages) or...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $147,656 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to St. Jude Children's Research Hospital Inc. to study how the mucus component mucin inhibits the autolysis (self-destruction) of the bacteria Streptococcus pneumoniae, which causes pneumonia and other respiratory infections. The research aims to determine the specific mechanisms by which mucin prevents pneumococcal...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $488,537 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Brigham & Women's Hospital Inc. on May 22, 2024 to characterize the production of Staphylococcus aureus extracellular membrane vesicles (MVs) during infection. The project aims to establish methodology for purifying and analyzing S. aureus MVs recovered from infected animal models, including murine air pouch and pneumonia models. It...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $868,776 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Children's Hospital Corporation (Boston Children's Hospital). The grant is to fund a 5-year project from February 2025 to January 2030 to characterize a novel post-transcriptional regulator in the opportunistic pathogen Pseudomonas aeruginosa. Key objectives include identifying the direct regulatory targets of...